Global Iodinated Contrast Market Research Report 2024

Publication ID:

PB506244043

Publication Date:

June 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Contrast agent refers to certain special substances often required to be applied in clinical examination and treatment in order to increase the contrast of a certain visceral tissue or cavity, and to more clearly display the shape, contour and lesion characteristics of organs or cavity. Contrast agents are commonly used as drugs containing different concentrations of iodine. The main iodine contrast agents are: Youweixian (iopromide), Shuangbei (iohexol), diatrizoate, sodium diatrizoate, iodinated oil, iodine (iodixanol) and so on.
The global Iodinated Contrast market was valued at US$ 3386 million in 2023 and is anticipated to reach US$ 4577.1 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The global iodinated contrast market refers to the market for diagnostic imaging agents that contain iodine-based compounds, commonly used in medical imaging procedures such as X-ray, computed tomography (CT), and angiography. Iodinated contrast agents are administered to enhance the visibility of blood vessels, organs, and tissues during these imaging procedures.
Here are some key points regarding the global iodinated contrast market:
Market Size and Growth: The iodinated contrast market has experienced steady growth over the years, driven by the increasing prevalence of chronic diseases and the growing demand for diagnostic imaging procedures. The market size is expected to expand further due to advancements in medical imaging technologies and the rising geriatric population, which often requires medical imaging for diagnosis and treatment monitoring.
Types of Contrast Agents: Iodinated contrast agents are available in various forms, including intravenous injectable agents, oral agents, and rectal agents. Intravenous contrast agents are most commonly used in CT scans and angiography, while oral and rectal contrast agents are used primarily to enhance visibility in gastrointestinal imaging.
Applications: Iodinated contrast agents are utilized in a wide range of diagnostic imaging procedures, including CT scans of various body parts (such as the chest, abdomen, and pelvis), angiography to image blood vessels, and other specialized imaging studies. They help improve the visualization of organs, blood vessels, and lesions during these procedures, aiding in accurate diagnosis and treatment planning.
Regulatory Considerations: The iodinated contrast market is subject to regulations and guidelines from global regulatory bodies, ensuring the safety and efficacy of these products. Regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) provide oversight and approval for iodinated contrast agents before they can be marketed and used in medical practice.
Key Market Players: The global iodinated contrast market is highly competitive, with several key players operating worldwide. These companies develop, manufacture, and market iodinated contrast agents. Some prominent market players in this industry include GE Healthcare, Bayer AG, Bracco Imaging S.p.A., Guerbet Group, and Ultraject.
Market Trends: Key trends in the iodinated contrast market include the development of low-osmolar and iso-osmolar contrast agents that offer enhanced patient safety and reduced adverse reactions. Additionally, there is a growing focus on research and development activities to develop innovative contrast agents with improved diagnostic capabilities and reduced nephrotoxicity.
This report aims to provide a comprehensive presentation of the global market for Iodinated Contrast, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iodinated Contrast.
Report Scope
The Iodinated Contrast market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Iodinated Contrast market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iodinated Contrast manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Lantheus
Daiichi Sankyo
Unijules Life Sciences
Sanochemia
Taejoon Pharm
Segment by Type
X-ray/Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Segment by Application
Radiology
Interventional Radiology
Interventional Cardiology
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Iodinated Contrast manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Iodinated Contrast by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Iodinated Contrast in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Iodinated Contrast Market Overview
1.1 Product Definition
1.2 Iodinated Contrast Segment by Type
1.2.1 Global Iodinated Contrast Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 X-ray/Computed Tomography (CT)
1.2.3 Magnetic Resonance Imaging (MRI)
1.3 Iodinated Contrast Segment by Application
1.3.1 Global Iodinated Contrast Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Radiology
1.3.3 Interventional Radiology
1.3.4 Interventional Cardiology
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Iodinated Contrast Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Iodinated Contrast Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Iodinated Contrast Production Estimates and Forecasts (2019-2030)
1.4.4 Global Iodinated Contrast Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Iodinated Contrast Production Market Share by Manufacturers (2019-2024)
2.2 Global Iodinated Contrast Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Iodinated Contrast, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Iodinated Contrast Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Iodinated Contrast Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Iodinated Contrast, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Iodinated Contrast, Product Offered and Application
2.8 Global Key Manufacturers of Iodinated Contrast, Date of Enter into This Industry
2.9 Iodinated Contrast Market Competitive Situation and Trends
2.9.1 Iodinated Contrast Market Concentration Rate
2.9.2 Global 5 and 10 Largest Iodinated Contrast Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Iodinated Contrast Production by Region
3.1 Global Iodinated Contrast Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Iodinated Contrast Production Value by Region (2019-2030)
3.2.1 Global Iodinated Contrast Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Iodinated Contrast by Region (2025-2030)
3.3 Global Iodinated Contrast Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Iodinated Contrast Production by Region (2019-2030)
3.4.1 Global Iodinated Contrast Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Iodinated Contrast by Region (2025-2030)
3.5 Global Iodinated Contrast Market Price Analysis by Region (2019-2024)
3.6 Global Iodinated Contrast Production and Value, Year-over-Year Growth
3.6.1 North America Iodinated Contrast Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Iodinated Contrast Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Iodinated Contrast Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Iodinated Contrast Production Value Estimates and Forecasts (2019-2030)
4 Iodinated Contrast Consumption by Region
4.1 Global Iodinated Contrast Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Iodinated Contrast Consumption by Region (2019-2030)
4.2.1 Global Iodinated Contrast Consumption by Region (2019-2024)
4.2.2 Global Iodinated Contrast Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Iodinated Contrast Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Iodinated Contrast Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Iodinated Contrast Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Iodinated Contrast Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Iodinated Contrast Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Iodinated Contrast Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Iodinated Contrast Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Iodinated Contrast Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Iodinated Contrast Production by Type (2019-2030)
5.1.1 Global Iodinated Contrast Production by Type (2019-2024)
5.1.2 Global Iodinated Contrast Production by Type (2025-2030)
5.1.3 Global Iodinated Contrast Production Market Share by Type (2019-2030)
5.2 Global Iodinated Contrast Production Value by Type (2019-2030)
5.2.1 Global Iodinated Contrast Production Value by Type (2019-2024)
5.2.2 Global Iodinated Contrast Production Value by Type (2025-2030)
5.2.3 Global Iodinated Contrast Production Value Market Share by Type (2019-2030)
5.3 Global Iodinated Contrast Price by Type (2019-2030)
6 Segment by Application
6.1 Global Iodinated Contrast Production by Application (2019-2030)
6.1.1 Global Iodinated Contrast Production by Application (2019-2024)
6.1.2 Global Iodinated Contrast Production by Application (2025-2030)
6.1.3 Global Iodinated Contrast Production Market Share by Application (2019-2030)
6.2 Global Iodinated Contrast Production Value by Application (2019-2030)
6.2.1 Global Iodinated Contrast Production Value by Application (2019-2024)
6.2.2 Global Iodinated Contrast Production Value by Application (2025-2030)
6.2.3 Global Iodinated Contrast Production Value Market Share by Application (2019-2030)
6.3 Global Iodinated Contrast Price by Application (2019-2030)
7 Key Companies Profiled
7.1 GE Healthcare
7.1.1 GE Healthcare Iodinated Contrast Corporation Information
7.1.2 GE Healthcare Iodinated Contrast Product Portfolio
7.1.3 GE Healthcare Iodinated Contrast Production, Value, Price and Gross Margin (2019-2024)
7.1.4 GE Healthcare Main Business and Markets Served
7.1.5 GE Healthcare Recent Developments/Updates
7.2 Bayer
7.2.1 Bayer Iodinated Contrast Corporation Information
7.2.2 Bayer Iodinated Contrast Product Portfolio
7.2.3 Bayer Iodinated Contrast Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Bayer Main Business and Markets Served
7.2.5 Bayer Recent Developments/Updates
7.3 Bracco Imaging
7.3.1 Bracco Imaging Iodinated Contrast Corporation Information
7.3.2 Bracco Imaging Iodinated Contrast Product Portfolio
7.3.3 Bracco Imaging Iodinated Contrast Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Bracco Imaging Main Business and Markets Served
7.3.5 Bracco Imaging Recent Developments/Updates
7.4 Guerbet Group
7.4.1 Guerbet Group Iodinated Contrast Corporation Information
7.4.2 Guerbet Group Iodinated Contrast Product Portfolio
7.4.3 Guerbet Group Iodinated Contrast Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Guerbet Group Main Business and Markets Served
7.4.5 Guerbet Group Recent Developments/Updates
7.5 Lantheus
7.5.1 Lantheus Iodinated Contrast Corporation Information
7.5.2 Lantheus Iodinated Contrast Product Portfolio
7.5.3 Lantheus Iodinated Contrast Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Lantheus Main Business and Markets Served
7.5.5 Lantheus Recent Developments/Updates
7.6 Daiichi Sankyo
7.6.1 Daiichi Sankyo Iodinated Contrast Corporation Information
7.6.2 Daiichi Sankyo Iodinated Contrast Product Portfolio
7.6.3 Daiichi Sankyo Iodinated Contrast Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Daiichi Sankyo Main Business and Markets Served
7.6.5 Daiichi Sankyo Recent Developments/Updates
7.7 Unijules Life Sciences
7.7.1 Unijules Life Sciences Iodinated Contrast Corporation Information
7.7.2 Unijules Life Sciences Iodinated Contrast Product Portfolio
7.7.3 Unijules Life Sciences Iodinated Contrast Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Unijules Life Sciences Main Business and Markets Served
7.7.5 Unijules Life Sciences Recent Developments/Updates
7.8 Sanochemia
7.8.1 Sanochemia Iodinated Contrast Corporation Information
7.8.2 Sanochemia Iodinated Contrast Product Portfolio
7.8.3 Sanochemia Iodinated Contrast Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Sanochemia Main Business and Markets Served
7.7.5 Sanochemia Recent Developments/Updates
7.9 Taejoon Pharm
7.9.1 Taejoon Pharm Iodinated Contrast Corporation Information
7.9.2 Taejoon Pharm Iodinated Contrast Product Portfolio
7.9.3 Taejoon Pharm Iodinated Contrast Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Taejoon Pharm Main Business and Markets Served
7.9.5 Taejoon Pharm Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Iodinated Contrast Industry Chain Analysis
8.2 Iodinated Contrast Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Iodinated Contrast Production Mode & Process
8.4 Iodinated Contrast Sales and Marketing
8.4.1 Iodinated Contrast Sales Channels
8.4.2 Iodinated Contrast Distributors
8.5 Iodinated Contrast Customers
9 Iodinated Contrast Market Dynamics
9.1 Iodinated Contrast Industry Trends
9.2 Iodinated Contrast Market Drivers
9.3 Iodinated Contrast Market Challenges
9.4 Iodinated Contrast Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Lantheus
Daiichi Sankyo
Unijules Life Sciences
Sanochemia
Taejoon Pharm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂